LD-2 disclosure · 1st Quarter - Report
ELI LILLY & CO.
Income$66Kfee reported
Client
- Name
- ELI LILLY & CO.
- Description
- pharmaceutical corporation
- Location
- District of Columbia · United States of America
Registrant
- Description
- strategic consulting/government affairs firm
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
2 issuesHealth Issues
drug pricing, Japan - pricing reform internationally
LobbyistsPHIL COX
Trade (domestic/foreign)
drug pricing, Japan - pricing reform internationally NAFTA OECD Trade Committee
LobbyistsPHIL COX · LARISSA MARTIN
TargetedExecutive Office of the President (EOP) · Office of the Vice President of the United States · U.S. Trade Representative (USTR) · Commerce, Dept of (DOC)